Product Details
Ozempic is a weekly injection that contains the active ingredient, semaglutide. Although it shares the same active ingredient as the popular weight loss injection, Wegovy, Ozempic has only been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) as a treatment for type 2 diabetes.
OZEMPIC® 0.5mg is an injectable medication used to improve glycemic control in individuals with type 2 diabetes. It is based on the active ingredient semaglutide, a GLP-1 receptor agonist, which helps lower blood glucose levels through various mechanisms, including stimulating insulin secretion and inhibiting glucagon release.
Reviews
There are no reviews yet.